Renal Cancer
Patient perspectives on the barriers associated with medication adherence to oral chemotherapy
December 2, 2016
Prediction of Competing Mortality for Decision Making between Surgery or Observation in Elderly Patients with T1 Kidney Cancer
November 29, 2016
Advances in Cancer Immunotherapy in Solid Tumors
November 28, 2016
Nivolumab dose selection: challenges, opportunities, and lessons learned for cancer immunotherapy
November 28, 2016
Sclerosing TFEB Rearrangement Renal Cell Carcinoma: A Recurring Histologic Pattern
November 26, 2016
Therapy of Treatment-Related Hypertension in Metastatic Renal-Cell Cancer Patients Receiving Sunitinib
November 25, 2016
[CCAFU french national guidelines 2016-2018 on renal cancer]
November 24, 2016
Prognostic significance of platelet-lymphocyte ratio in patients receiving first-line tyrosine kinase inhibitors for metastatic renal cell cancer
November 24, 2016
The database of the Danish Renal Cancer Group
November 24, 2016
Resistance to Targeted Therapies in Renal Cancer: The Importance of Changing the Mechanism of Action
November 23, 2016
Predictive and prognostic biomarkers of targeted agents and modern immunotherapy in renal cell carcinoma
November 22, 2016
Image guided radiofrequency ablation for small renal masses
November 21, 2016
Presence of sarcomatoid differentiation as a prognostic indicator for survival in surgically treated metastatic renal cell carcinoma
November 21, 2016
Cytoreductive Nephrectomy in the Tyrosine Kinase Inhibitor Era: A Question That May Never Be Answered
November 17, 2016
Active surveillance for incidental renal mass in the octogenarian
November 17, 2016